-
Less chemotherapy allows for better quality of life and easier transition toward death for cancer patients in the last phases of life, according to researchers at Virginia Commonwealth University Massey Cancer Center.
-
The National Hospice and Palliative Care Organization (NHPCO) has filed a lawsuit to stop a Centers for Medicare and Medicaid Services (CMS) rule that would cut hospice reimbursement rates.
-
Do you assume that employees with methicillin-resistant Staphylococcus aureus (MRSA) skin infections need to be routinely excluded from work?
-
An aging workforce and a nursing shortage might seem like the perfect storm for the health care industry, but all areas of health care, including hospice organizations, have found ways to attract, retain, and make the best use of experience that comes with age.
-
-
Rewind to 2007. A large HIV vaccine clinical trial sponsored by Merck & Co. is shuttered after an interim analysis concluded that the vaccine did not prevent infection. Fast forward to today.
-
The Population Council, a New York City-based reproductive health research organization, and Sheldon Segal, PhD, distinguished scientist at the council, have been scheduled to receive the 2008 Prix Galien USA Pro Bono Humanum Award for their role in developing implantable hormone delivery systems.
-
As you move through your busy day at the clinic, how are you providing important sexually transmitted disease (STD) prevention messages to your patients? If caseload and budgetary restrictions are impeding your intentions, take a look at using a brief waiting room video intervention to complement your efforts.
-
What is your clinic's policy when it comes to getting a signed informed consent for HIV testing? By eliminating required written consent for HIV testing at the San Francisco Department of Public Health Medical Center, the average monthly rate of HIV tests has increased by 4.38 per 1,000 patient-visits, with a 67% increase (from 8.9 to 14.9) in the monthly average number of new positive HIV tests.
-
Talk with your patients about fraudulent drugs sold over the Internet as treatment for sexually transmitted diseases (STDs). The Food and Drug Administration (FDA) has issued warning letters to six U.S. companies and one foreign individual for marketing unapproved and misbranded drugs over the Internet to U.S. consumers for STD prevention and treatment.